U.S. Markets open in 5 hrs 8 mins

Titan Pharmaceuticals, Inc. (TTNP)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.60+0.05 (+3.23%)
At close: 3:59PM EDT
People also watch
VNDABDSIIMUCONCSNAVB
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue15,0651,6713,646
Cost of Revenue---
Gross Profit15,0651,6713,646
Operating Expenses
Research Development6,1264,6754,075
Selling General and Administrative4,5963,7553,046
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss4,343-6,759-3,475
Income from Continuing Operations
Total Other Income/Expenses Net792-4,5201,072
Earnings Before Interest and Taxes5,135-11,279-2,403
Interest Expense---
Income Before Tax5,135-11,279-2,403
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops5,135-11,279-2,403
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income5,135-11,279-2,403
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares5,135-11,279-2,403